VIEMED HEALTHCARE, INC.
Company Stats
- Market Cap
- $346.6M
- as of Sep 30, 2026
- Shares Outstanding
- 38.1M
- Free Float
- 65.0%
Income Statement
- Revenue
- $270.3M
- Operating Income
- $22.9M
- Net Income
- $14.9M
- EBITDA
- $51.6M
- Revenue Growth, 3Y
- 24.9%
- FCF Margin, 3Y Avg
- 5.1%
- FCF Margin, Worst Year
- 0.6%
Cash Flow
- Free Cash Flow
- $11.9M
- FCF Yield
- 3.4%
- Owner FCF Yield
- 0.8%
Balance Sheet
- Cash & Equivalents
- $13.5M
Returns & Capital
- Share Repurchases
- $13.2M
- Buyback Yield, 3Y Avg
- 1.3%
- SBC, 3Y Avg
- $7.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $270.3M | $11.9M | 4.4% |
| FY2024 | $224.3M | $1.3M | 0.6% |
| FY2023 | $183.0M | $19.1M | 10.4% |
| FY2022 | $138.8M | $4.8M | 3.5% |
| FY2021 | $117.1M | $2.8M | 2.4% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back